Clinical Trials Browser

Withdrawn × Squamous Cell Carcinoma of Head and Neck × cemiplimab × Clear all

NCT04831450 2022-08-04

Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC)

Phase 2 Withdrawn

Squamous Cell Carcinoma of Head and Neck